trending Market Intelligence /marketintelligence/en/news-insights/trending/dhEkZ2v9YOVGjYdRfy0tig2 content esgSubNav
In This List

Oncolytics Biotech's interim CEO to head company on a permanent basis

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Oncolytics Biotech's interim CEO to head company on a permanent basis

Oncolytics Biotech Inc. appointed Matt Coffey as president and CEO, effective immediately.

Coffey was named the company's interim president and CEO in November 2016.